Navigation Links
Mother's immunosuppressive medications not likely to put fetus at risk
Date:11/8/2013

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

The paper is one of the first to describe risks for medications used to treat autoimmune diseases when taken during pregnancy, according to first author William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and professor of Health Policy at Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, Tenn.

"This study is important because these conditions affect nearly 4.5 million persons in the U.S., including many women of childbearing age," Cooper said. "Currently, there are almost no data to guide women who are pregnant, or planning to become pregnant, who may need to continue their medications during pregnancy."

Study authors used health plan data from Tennessee Medicaid, Kaiser Permanente Northern California and Southern California, linked with vital records and medical records. The three geographically diverse health plans collectively provide coverage for more than 8 million persons each year.

The cohort included 608 infants, including 437 with exposure during pregnancy and 171 whose mothers filled prescriptions for immunosuppressives before, but not during, pregnancy.

Women with rheumatoid and psoriatic arthritis, ankylosing spondylitis, lupus, scleroderma, and inflammatory bowel disease who filled prescriptions for immunosuppressive treatments during pregnancy were included in the study.

The drugs studied included hydroxychloroquine, tumor necrosis factor (TNF) inhibitors and other immunosuppressives such as sulfasalazine and azathioprine.

When compared with the women who had medication treatment before, but not during, pregnancy the risk ratios for adverse fetal outcomes associated with immunosuppressive use during pregnancy were not statistically significant, the authors reported.

Cooper said some of the medications in the study are relatively new and therefore haven't been extensively used in pregnancy. As use continues to expand, follow-up studies will be important to ensure that new safety signals aren't detected.

"One of the things we find in studying drug exposures in pregnancy is that, because up to 50 percent of pregnancies are unplanned, women may be taking a medication and become pregnant while still taking a potentially harmful drug," Cooper said. "Therefore, it's very important for women who have conditions that require medical treatments to talk with their providers about potential risks of medications in pregnancy."


'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Low-Income Mothers May Overfeed Their Infants
3. Canadian teen moms run higher risk of abuse, depression than older mothers
4. Study finds that single mothers can reduce stress by playing, engaging with children
5. Study suggests poor mothers favor daughters
6. Making bad worse for expectant mothers
7. New hospital guidelines to help mothers at risk of postpartum depression
8. Lower iron levels seen in newborns of obese mothers
9. Babies Born to Obese Mothers May Have Low Iron: Study
10. Study Ties Infant Birth Weight to Mothers Breast Cancer Risk
11. Pregnant Mothers Gut Changes May Support Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... ... October 16, 2018 , ... Bastyr University is pleased ... Integrative Health and Medicine’s (AIHM) Visionary Award for his passionate efforts in forging ... was selected as AIHM’s recipient of the Visionary Award due to his tireless ...
(Date:10/16/2018)... ... ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has announced the ... first G7 country in the world to formally legalize the recreational production and use ... production and use of cannabis edibles. , More than one in four Canadians aged ...
(Date:10/16/2018)... Del. (PRWEB) , ... October 16, 2018 , ... ... of First Healthcare Compliance, an attorney experienced in employment law, writes frequently on ... other publications. Recently, she authored a chapter in the Health Care Compliance Professional's ...
(Date:10/16/2018)... (PRWEB) , ... October 16, 2018 , ... The months of training are over. The ... their bodies will probably feel like they were put through the wringer after the big ... sports injuries team at Medicine in Motion on how to treat the body and mind ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... research networking-technology company founded by patient-survivors, and The Avoca Group, Inc., a ... clinical trial execution process, today announced its mutual collaboration that will make ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... ... October 11, 2018 , ... doeLEGAL, a leading provider ... and law firms, today announced it is sponsoring the 2018 ACC Annual Meeting ... how corporate legal departments are using smart data, intelligently delivered to rethink data ...
(Date:10/11/2018)... ... October 11, 2018 , ... In the last four months it has ... families and allowance of six more in USA, China and Japan from three other ... MRI safety and security products. , The patents assigned from QinetiQ include US 7113092, ...
(Date:10/7/2018)... ... ... likes to think about an emergency, even what might seem like small water damage ... professional, a trusted leader in the restoration industry, has a list of tips to help ... a good time for an emergency, but having a few things in order way ahead ...
Breaking Medicine Technology: